SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login

    • DNA Shed From Colon Cancers Into Bloodstream Guide Chemotherapy

    DNA Shed From Colon Cancers Into Bloodstream Guide Chemotherapy

    A new research study showed that circulating tumor DNA (ctDNA) — genetic material shed from tumors into the bloodstream — can identify those stage II colon cancer patients who can most benefit from chemotherapy following surgery. Learn more about this study and how patients will benefit.

    SEE ALL NEWS
    Recent Posts
    First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma Treatment Resistance in Prostate Cancer Elaine’s Story: A Journey of Strength, Faith, and Healing at Johns Hopkins In Extensive Sequencing Study, Scientists Find Few Links Between Cancer and Microbiome Johns Hopkins Investigators Create New Urine-based Test to ID Prostate Cancers New therapy kickstarts immune response to cancer Prostate Cancer Treatment: What to Do When It Stops Working 5 Healthy Habits That Help During Cancer Treatment Understanding Mammogram Results
    Johns Hopkins

    2026 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top